19 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
recruitment and retention efforts are unsuccessful in the future, it may be difficult for us to achieve our development objectives, raise additional … treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial, or could result
6-K
MREO
Mereo Biopharma Group Plc
9 May 22
Current report (foreign)
8:06am
of recruitment challenges and this change was implemented during the COVID-19 pandemic. The Company made the decision to close the study when it was determined
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
9 May 22
Current report (foreign)
8:06am
announced, the protocol allowed prioritization of enrollment to the high dose arm in the case of recruitment challenges and this change was implemented
6-K
EX-99.1
5zd xxsn5mbfx
14 Mar 22
Current report (foreign)
10:05am
6-K
rioalgxionhcl
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-99.1
0ld0 ojtun
27 Mar 20
Business Update and Directorate Change
9:09am
F-1/A
d4x bqu6gqyhizlk
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
j5uk4pfa10hxmb5of
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
64qtkmrvp72afwt81
17 Sep 19
Current report (foreign)
8:06am
6-K
EX-10.1
vgmh69id vuoqhs
3 Sep 19
Current report (foreign)
4:05pm
6-K
n1a eep1867
3 Sep 19
Current report (foreign)
4:05pm
20-F
s38cmwwp7
29 Apr 19
Annual report (foreign)
4:59pm
424B3
yki5uk oulvgz1i6m
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
wxbt lrl0h
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
7me3gg33tzk49 5kfo
25 Jan 19
Registration of securities (foreign)
12:00am
- Prev
- 1
- Next